secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K/A
Filed at:   2026-06-30T10:01:12+00:00
Accession:  0001295947-26-000025
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acquired OTC Wellness Business Q1 net sales $51.7M, net income $12.6M
---------------------------------------------------------------------

- Net sales of $51.7M for Q1 2026, up 2.4% from $50.5M in Q1 2025.
- Net income of $12.6M, down 14.4% from $14.8M in prior-year quarter.
- Intangible assets net of $328.3M and goodwill of $151.5M as of March 31, 2026.
- Business includes brands Breathe Right, Dimetapp, Anbesol, Alavert, Primatene, and others.
- Pro forma financials for Prestige Consumer Healthcare also filed as part of the acquisition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000129594726000025/0001295947-26-000025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000129594726000025/pbh-20260612.htm
  HTML page:      https://secwatch.observer/filing/0001295947-26-000025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer